The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant chemoradiation therapy with 5-FU/LV (INT-0116) versus S-1 chemotherapy in completely resected gastric cancer: Practice pattern and feasibility at a single institution.
Deok Won Hwang
No relevant relationships to disclose
Su Jin Lee
No relevant relationships to disclose
Jeeyun Lee
No relevant relationships to disclose
Se Hoon Park
No relevant relationships to disclose
Joonoh Park
No relevant relationships to disclose
YoungSuk Park
No relevant relationships to disclose
Hoyeong Lim
No relevant relationships to disclose
WonKi Kang
No relevant relationships to disclose